Skip to main content


Fig. 6 | Clinical and Translational Allergy

Fig. 6

From: Does clinical outcome of birch pollen immunotherapy relate to induction of blocking antibodies preventing IgE from allergen binding? A pilot study monitoring responses during first year of AIT

Fig. 6

Graphical illustration of assays used for measuring the AIT-induced capacity of antibodies to prevent IgE-Bet v 1 binding. FAB (a) and inhibition mediator release assays with T0 serum of each patient (b) or indicator serum pool (c) used as reference for therapy-induced antibodies to inhibit IgE-allergen binding

Back to article page